NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
  • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    The Motley Fool
    Investing

    3 CEOs Who Actually Earn Their Pay

    The former CEO of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), Michael Pearson, was the highest-paid CEO in Canada at $182.9 million.…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: A Stock at the Top of My List!

    Going into 2017, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are at the top of my watch list.

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Will Fail to Re-Invent Itself

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) had a horrible year, and I believe the stock is far from rallying.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Stay on the Sidelines

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could experience wonderful growth, but for now, it's best to avoid it because it is…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Buy Now, Say Analysts

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been hit hard by recent scandals and poses significant speculative risk to investors. At…

    Read more »

    The Motley Fool
    Energy Stocks

    Valeant Pharmaceuticals Intl Inc. vs. Baytex Energy Corp.: Which Is a Better Bet?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and Baytex Energy Corp. (TSX:BTE)(NYSE:BTE) are two of Canada's fallen stars. Is one about to…

    Read more »

    The Motley Fool
    Investing

    Saving Face at Valeant Pharmaceuticals Intl Inc.

    Is the fate of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) really in its own hands?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: A Year in Review

    Few companies had a memorable 2016 as much as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Here's a look at how the…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Will Continue to Be a Loser in 2017

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) was a loser in 2016 and will continue to be a loser in 2017 as…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Next Stop $10?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) remains a risky bet.

    Read more »

    The Motley Fool
    Investing

    Is Kevin O’Leary Right About Valeant Pharmaceuticals Intl Inc.?

    Many investors are quite bearish on Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), including Kevin O'Leary. Is Mr. Wonderful on to something…

    Read more »

    The Motley Fool
    Investing

    Making the Case for Valeant Pharmaceuticals Intl Inc.: Why it’s Not Worth it Yet

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) stock has been in shambles in 2016, plummeting more than 83%, but there is reason…

    Read more »